SCP
TMDX icon

Sandhill Capital Partners’s Transmedics TMDX Stock Holding History

Sandhill Capital Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,674
Closed -$300K – 108
2025
Q3 		$300K Sell
2,674
-953
-26% -$112K 0.02% 87
2025
Q2 		$486K Hold
3,627
– – 0.03% 69
2025
Q1 		$244K Sell
3,627
-174,383
-98% -$12M 0.02% 83
2024
Q4 		$11.1M Sell
178,010
-214,551
-55% -$20M 0.87% 28
2024
Q3 		$61.6M Sell
392,561
-42,413
-10% -$6.54M 4.39% 6
2024
Q2 		$65.5M Sell
434,974
-298,697
-41% -$35.8M 5.03% 3
2024
Q1 		$54.2M Sell
733,671
-29,530
-4% -$2.43M 4.34% 5
2023
Q4 		$60.2M Buy
763,201
+30,591
+4% +$1.85M 5.01% 3
2023
Q3 		$40.1M Sell
732,610
-80,234
-10% -$5.78M 3.75% 10
2023
Q2 		$68.3M Sell
812,844
-174,773
-18% -$13.4M 6.22% 2
2023
Q1 		$74.8M Sell
987,617
-216,133
-18% -$14.9M 7.17% 1
2022
Q4 		$74.3M Sell
1,203,750
-139,413
-10% -$7.41M 7.93% 1
2022
Q3 		$56.1M Sell
1,343,163
-244,394
-15% -$10.6M 6.4% 1
2022
Q2 		$49.9M Sell
1,587,557
-323,185
-17% -$8.62M 5.34% 1
2022
Q1 		$51.5M Buy
1,910,742
+105,224
+6% +$1.89M 4.42% 2
2021
Q4 		$34.6M Buy
1,805,518
+365,473
+25% +$9.16M 2.69% 20
2021
Q3 		$47.7M Buy
1,440,045
+10,613
+0.7% +$324K 3.82% 7
2021
Q2 		$47.4M Buy
1,429,432
+232,093
+19% +$6.43M 3.7% 7
2021
Q1 		$49.7M Sell
1,197,339
-53,122
-4% -$1.63M 4.21% 2
2020
Q4 		$24.9M Buy
1,250,461
+96,130
+8% +$1.42M 2.27% 23
2020
Q3 		$15.9M Buy
1,154,331
+398,608
+53% +$6.83M 1.6% 31
2020
Q2 		$13.5M Sell
755,723
-15,275
-2% -$239K 1.59% 30
2020
Q1 		$9.31M Buy
770,998
+34,823
+5% +$583K 1.25% 34
2019
Q4 		$14M Buy
736,175
+240,149
+48% +$4.41M 1.55% 31
2019
Q3 		$11.8M Buy
+496,026
New +$11.9M 1.44% 32

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Sandhill Capital Partners's TMDX Position: Q4 2025 in Review

Sandhill Capital Partners sold out of Transmedics (TMDX) in Q4 2025, closing a stake of 2,674 shares — an estimated $300K sold.

Sandhill Capital Partners first reported a position in TMDX in Q3 2019 and held it in 25 quarters. The position peaked at $74.8M in Q1 2023. 428 funds tracked by Wall St. Rank hold TMDX as of Q4 2025.

  • Sandhill Capital Partners reported no remaining Transmedics position as of Q4 2025 after selling out during the quarter.
  • Sandhill Capital Partners sold 2,674 Transmedics shares in Q4 2025, an estimated $300K.
  • Sandhill Capital Partners first reported a position in Transmedics in Q3 2019 and held it in 25 quarters.
  • Sandhill Capital Partners's Transmedics position peaked at $74.8M in Q1 2023.
  • 428 funds tracked by Wall St. Rank held Transmedics as of Q4 2025.

Based on Sandhill Capital Partners's 13F filing for Q4 2025, filed 12 Feb 2026.